J W Langston Selected Research

J W Langston Research Topics

10	Parkinson Disease (Parkinson's Disease) 01/2005 - 01/2000
7	Dyskinesias (Dyskinesia) 01/2005 - 01/2000
6	Parkinsonian Disorders (Parkinsonism) 08/2007 - 01/2000
1	Neoplasms (Cancer) 10/2000
1	Nervous System Diseases (Neurological Disorders) 09/2000
1	Glioma (Gliomas) 05/2000
1	Disease Progression 05/2000
1	MPTP Poisoning 04/2000

8	Levodopa (L Dopa)FDA LinkGeneric 01/2005 - 01/2000
6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2005 - 01/2000
3	Dopamine (Intropin)FDA LinkGeneric 12/2000 - 01/2000
2	Messenger RNA (mRNA)IBA 01/2005 - 01/2002
2	Carboplatin (JM8)FDA LinkGeneric 10/2000 - 05/2000
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2000 - 01/2000
1	Dopa-responsive DystoniaIBA 08/2007
1	triphosphoric acid (triphosphate)IBA 01/2005
1	GTP-Binding Proteins (G-Protein)IBA 01/2005
1	LigandsIBA 01/2005
1	Opioid Peptides (Opioid Peptide)IBA 01/2005
1	Opioid Receptors (Opioid Receptor)IBA 01/2005
1	Guanosine 5'-O-(3-Thiotriphosphate)IBA 01/2005
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 10/2004
1	entacapone (Comtan)FDA Link 10/2004
1	preproenkephalinIBA 01/2002
1	parkin proteinIBA 09/2001
1	Carbidopa (Lodosyn)FDA LinkGeneric 08/2001
1	Selegiline (E250)FDA LinkGeneric 12/2000
1	NADH DehydrogenaseIBA 12/2000
1	RotenoneIBA 12/2000
1	Tamoxifen FDA LinkGeneric 05/2000
1	Nicotinic AgonistsIBA 01/2000
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2000
1	harpin (messenger)IBA 01/2000

2	Drug Therapy (Chemotherapy) 09/2000 - 05/2000